Susan Hasty, Publisher
Table of Contents . . . September 27th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Liver Disease - Silent hepatitis B does not alter hepatitis C-related liver disease
Environmental Health - Combined technologies detect hepatitis A virus in environmental samples
Immunology - Fine-needle aspiration biopsies predict how hepatitis C will respond to therapy
Liver Fibrosis - Hepatitis B virus X antigen activates fibrinogen gene expression
Recombinant Research - Lymphoblastoid interferon may clear hepatitis B better than recombinant therapy
Antiviral Therapy - Chronic hepatitis C nonresponders are a challenge to clinical management
Business & Finance - Novo Nordisk A/S completes investment in biopharma company
Cancer Therapy - J-tipped guidewire suitable for RPCS placement through subclavian artery
Chronic Hepatitis C - Over-reaction to CD1d-presented liver antigens promotes liver injury
Diagnostics - CMV-DNA and pp65-antigen tests predict human cytomegalovirus symptom onset
Disease Associations - Diabetes after kidney transplant on the rise
Disease Associations - Lymphoproliferative disorders flourish with hepatitis C virus infections
Finance - Biopharmaceutical company reports limited strong revenue growth for FY 2004
Gene Therapy - RNA interference is a potent tool for gene-specific therapeutics
HIV/AIDS Coinfection - Dissociation found between serum and liver HCV RNA in HIV/HCV coinfection
HIV/AIDS Coinfection - HAART increases rate of hapatotoxicity in hepatitis C virus coinfection
HIV/AIDS Coinfection - Hepatitis C virus type 5 highly prevalent in central France from 1996 to 2002
HIV/AIDS Diagnostics - Bayer Versant bDNA HIV and HCV assays run together for improved workflow
Hematology - Biopharma company confirms evidence of PBI-1402's positive effect
Hepatitis - Application filed to market Pegasys for hepatitis and AIDS coinfection
Hepatitis - Conserved hepatitis C E2 protein binding regions steer T-cell binding affinity
Hepatitis B Vaccine - Dendritic cell vaccine for hepatitis B infection therapy is promising
Hepatitis B Vaccine - Hepatitis vaccine nonresponse linked to impaired lymphocyte activation
Hepatitis B Virus - Structure of glycans in hepatitis B virus surface proteins determined
Hepatitis C - Report describes long-term outcomes for liver transplantation
Hepatitis C Virus - A novel C-terminal motif guides HCV core protein to mitochondrial localization
Hepatitis Delta Virus - Large hepatitis D virus antigen regulates amber/W editing and viral assembly
Hepatitis Vaccine - Enrollment complete for phase II/III hepatitis B prophylactic vaccine trial
Infection - A select series of steps guides hepatitis B virus entry into cells
Liver Cancer - 1,25-Dihydroxyvitamin D-3 is a potent hepatocellular carcinoma destroyer
Liver Cancer - FDA will allow trials for the use of ThermoDox with RFA for liver cancer
Oncovirus - Occult hepatitis B virus in liver cancer is uncommon where chronicity is low
Pathology - Liver biopsies are essential for evaluating patients with chronic hepatitis C
Septic Shock - Effects of endotoxin on hepatic gene expression characterized
Stem Cell Research - Bone marrow stromal cells alternative source for SCT in liver repair
Transfusion Medicine - Fatalities caused by transfusion-related acute lung injury reviewed
Viral Genomics and Genetics - Adaptive mutations favor the replication of hepatitis C virus genotype 1a
Virology - Common viruses use La autoantigen for IRES-dependent translation
Virology - L surface antigen regulates superinfection exclusion in hepadnavirus infections
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.